Printer Company Develops Drug-Injection Patch

'Squirting drugs' like 'squirting ink,' says exec

By Sam Gale Rosen, Newser Staff

Posted Sep 12, 2007 1:30 AM CDT

(Newser) – Printer manufacturer Hewlett-Packard is teaming up with an Irish company to develop a skin patch that delivers precisely controlled amounts of drugs with tiny needles. The drug delivery system uses some of the same technology as ink printers, and could inject different drugs at different times. "Squirting ink and squirting drugs— it's not a whole lot different," said one executive.

The technology could provide the equivalent of a thousand hypodermic needles per square inch that are all electronically controlled, according to a company spokesman. The system could be ready as early as 2010, and is expected to be relatively cheap. The patches could last for days or weeks, and would be particularly useful to patients who need to take several drugs on a complicated schedule.

[Images (2)]

[Videos (1)]

Hewlett Packard products are seen on the shelf at a Best Buy in Cambridge, Mass., in this May 16, 2007 file photo. The technology behind these Inkjet cartridges might soon be applied to time-release medicinal... (Associated Press)

The logo for Hewlett-Packard. The printing giant recently announced a partnership with an Irish company to help develop drug patches for skin. (Getty Images)

« Prev« Prev | Next »Next » Slideshow

Hewlett-Packard short-film advertisement, "Tea Runner". (kuzetar (YouTube))

View larger videos >>

« Prev« Prev | Next »Next »

To report an error on this story, notify our editors.

More Newser Stories

FDA Takes Over 3 Tylenol Plants

Johnson & Johnson division under scrutiny for manufacturing practices

(NEWSER) - After multiple drug recalls and an FDA safety probe, federal authorities are taking control of three Tylenol plants, CNNMoney reports. The plants, run by Johnson & Johnson’s McNeil division, are in trouble for dodging federal manufacturing rules; now, the company has agreed to let the FDA supervise the three—two in Pennsylvania and one in Puerto Rico—a decision that effectively wards off a threatened FDA lawsuit. The agreement, a so-called "consent decree," is subject to a Pennsylvania judge’s approval. More»

Are Your Meds Working? Gene Tests Could Tell

Docs could eliminate half of drugs genetics prevent from working

(NEWSER) - The drugs you take may not actually be working. Experts say that, thanks to various genetic quirks, most drugs only work for about half the people who take them, meaning that much of the roughly $300 billion America spends on drugs each year is wasted. That’s why forward-looking doctors are fixated on the holy grail of “personalized medicine”—the idea of using genetic tests to ensure each patient gets the right drugs. More»

Patients Could Polish Their Bedside Manner, Docs Say

Lousy rapport impairs treatment, survey finds

(NEWSER) - Odds are you're annoying your doctor, according to a Canadian study that asked nearly 300 physicians about their daily frustrations. As the Globe and Mail reports, many had difficulty establishing rapports with patients, who routinely resisted or flouted their advice —which can lead to patient safety problems. “When you have patients that can't communicate, there's going to be a big issue,” said one of the study’s authors. More»

Congress: No More Scribbled Scrips, Doc

Legislation will nudge MDs toward electronic prescription system

(NEWSER) - Senators from both sides of the aisle are pushing doctors away from their prescription pads and towards electronic prescribing, the Chicago Tribune reports. Politicians and lobbyists hope the new system will cut down on mis-filled prescriptions and harmful, but avoidable, drug interactions. More»

New Blood Thinner Tops Plavix in Trials

But prasugrel also adds risk of bleeding to death

(NEWSER) - An experimental new blood-thinner looks like real competition for top-selling anti-clotting drug Plavix, after proving more effective at preventing heart attacks, strokes, and heart-related death in a recent trial, the AP reports. But “there is a price to pay” for increased effectiveness, wrote one doctor—the new drug caused an extra bleeding death for each heart-related one it prevented. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Printer Company Develops Drug-Injection Patch